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Fusobacterium infection should be considered in
the pathogenesis of recurrent pharyngitis and
can lead to Lemierre’s syndrome if left untreated.
Case history
A 25-year-old non-smoking warehouse worker
presented to the acute medical take with a
ﬁve-day history of worsening symptoms includ-
ing anorexia, lethargy, myalgia, swinging fevers
and night sweats. He had been seen by his
general practitioner at the start of this illness and
commenced on oseltamivir to treat presumed
H1N1 inﬂuenza; subsequent hospital referral
was prompted by worsening oral intake, dys-
pnoea, productive cough and pleuritic chest
pain. There was no past medical history of note
except the patient’s report of having suffered
from a severe sore throat causing odynophagia a
fortnight previously, along with a bout of milder
pharyngitis in the weeks prior to this. On admis-
sion the patient was febrile (38.1˚C), tachycardic
(120 bpm) and hypotensive (106/61 mmHg).
Pulmonary examination demonstrated globally
reduced air entry and expansion with right basal
bronchial breathing. Routine bloods (Table 1)
were consistent with systemic sepsis and multi-
organ dysfunction including acute renal failure,
early disseminated intravascular coagulation and
type 1 respiratory failure. Plain chest radiograph
(Figure 1) showed extensive ill-deﬁned consolida-
tion. The patient was diagnosed with bilateral
community-acquired pneumonia on a possible
background of H1N1 inﬂuenza and commenced
on intravenous ﬂuid resuscitation and dual
antibiotic therapy (co-amoxiclav and clarithromy-
cin) as per hospital guidelines.
Despite optimal medical management the
patient deteriorated over the next 12 hours with
worsening hypotension and hypoxaemia, necessi-
tating transfer to a High Dependency Unit for
cardio-respiratory support. Urinary Legionella and
Pneumococcal antigens along with H1N1 viral PCR
were negative. Blood cultures taken on admission
grew anaerobic Gram-negative rods, subsequently
characterized as Fusobacterium necrophorum sensi-
tive to co-amoxiclav and metronidazole. Whole-
body computerized tomography performed to
identify a thrombotic focus for infection conﬁrmed
the presence of a left internal jugular vein thrombo-
sis with widespread bilateral lung consolidation
and pleural effusions (Figure 2). Intercostal chest
drain insertion was performed for the larger right
effusion to optimize respiratory function and sub-
cutaneous dalteparin started for the jugular vein
thrombosis. A diagnosis of Lemierre’s syndrome
was made on the basis of the clinical ﬁndings.
The patient improved enough to return to a
general medical ward after ﬁve days, and was sub-
sequently discharged home with improving bio-
chemical markers after four weeks in hospital. He
received a total of seven weeks’ broad-spectrum
intravenous antibiotic therapyand has been contin-
ued on oral anticoagulation for three months with
ongoing outpatient medical follow-up.
Discussion
Descriptions of post-anginal anaerobic septicaemia
following a sore throat can be found in the medical
literature from the beginning of the 20th century; it
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1was Lemierre, though, who clearly deﬁned a syn-
drome linking recurrent pyrexia, rigors, septic
thrombophlebitis and distal embolic infarcts (e.g.
pulmonary)followinga sore throat tobe ‘so charac-
teristic that mistake isalmost impossible’.
1 The case
frequency and high mortality rate reported by
Lemierre declined with the advent of widespread
antibiotic usage for bacterial pharyngitis, leading
his syndrome to be labelled as another forgotten
disease. However, recent work has suggested that
its incidence may be rising again, perhaps as a
result of concern regarding antibiotic overuse and
resistance, changes in prescribing practice and
even reduction in the number of tonsillectomies
now being performed.
2–4
Fusobacterium necrophorum is the most common
pathogen associated with Lemierre’s syndrome;
a recent review labelled it as responsible for 68%
of cases in the published literature, while 86%
grew any member of the Fusobacterium species.
3
Despite initial claims (including by Lemierre
himself) that the organism was part of the
normal oral ﬂora, it is now acknowledged that
Table 1
Blood results on admission (reference values in italics)
Hb 13.1 g/dL (13.0–17.0) PT 12.9 sec (9.0–15.0)
WCC 13.9× 10
9/L (3.7–11.1) APTT 30.0 sec (25.0–35.0)
Plts 21× 10
9/L (150–400) Fibrinogen 5.51 g/L (1.8–4.5)
Sodium 131 mmol/L (135–145) corr.Calcium 2.3 mmol/L (2.15–2.70)
Potassium 3.1 mmol/L (3.3–4.4) Magnesium 1.0 mmol/L (0.7–1.0)
Chloride 91 mmol/L (101–112) Bilirubin 47 mol/L (3–17)
Bicarbonate 25.4 mmol/L (21–31) AST 44 iu/L (16–50)
Urea 27.4 mmol/L (3.0–6.5) ALP 201 iu/L (42–114)
Creatinine 241 mol/L (55–105) GGT 21 iu/L (12–62)
CRP 375 mg/L (0–6.0) Albumin 21 g/L (32–50)
ABG pH 7.45 pO2 7.63 kPa pCO2 3.33 kPa (taken on room air)
Figure 1
Plain chest radiograph on admission
demonstrating widespread consolidation in
keeping with a bilateral pneumonic process
Figure 2
Axial CT image demonstrating a ﬁlling defect in
the left internal jugular vein (circled) consistent
with thrombosis
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2Fusobacterium should always be considered a
pathogen, particularly when isolated in culture
from sterile sites. Lemierre’s syndrome classically
occurs in young adult men, with the proposed
pathological sequence of events being that the
organism causes tonsillitis and peritonsillar
abscess before invading the lateral pharyngeal
space and deep neck structures (including the
internal jugular vein) to cause complications
such as bacteraemia, thrombophlebitis and deep
abscess formation. Predisposing factors described
in the medical literature for developing Lemierre’s
syndrome have included trauma to the orophar-
nyx (allowing direct invasion by Fusobacterium),
concurrent infection with Epstein-Barr virus and
acquired or inherited thrombophilic states.
The place of anticoagulation in Lemierre’s syn-
drome is unclear; no objective evidence exists to
establish its usefulness in managing thrombosis
associated with the infection,
5 and any decision
to start treatment is generally extrapolated from
personal clinician experience with other con-
ditions that cause septic embolic phenomena.
Antibiotic therapy should provide appropriate
anaerobic and beta-lactamase resistant cover
with typical therapeutic choices including
co-amoxiclav, piperacillin-tazobactam and/or
metronidazole. Various studies have shown Fuso-
bacterium necrophorum to be reliably sensitive to
these antibiotics; by contrast there is evidence of
resistance to penicillins (2%) and particularly
macrolides (15%) among UK isolates referred for
analysis in recent years,
4 while Fusobacterium
necrophorum also tends to be intrinsically resistant
to gentamicin, quinolones and tetracyclines.
Considering the antibiotics commonly pre-
scribed for bacterial pharyngitis in the primary
care setting, this proﬁle of resistance may be of
particular relevance if assessing a patient who
has presented with either recurrent or deteriorat-
ing symptoms of pharyngitis despite apparent
treatment. Indeed, there is a signiﬁcant body of
evidence implicating Fusobacterium necrophorum
in the pathogenesis of conventional bacterial
pharyngitis. A number of prospective studies
havedemonstratedthatwhenculturedforFusobac-
teriumnecrophorumcanbeidentiﬁedinaround10%
of all routine throat swabs received by a micro-
biology laboratory,
6,7 comparing favourably with
the most common organism and textbook cause
of bacterial pharyngitis, group A beta-haemolytic
Streptococcus (isolated in 11–13% of cultures in
the same studies). The results also highlight an
increased prevalence of Fusobacterium necrophorum
in young adults with pharyngitis, where in one
study the organism was responsible for 77% of
positive cultures in swabs taken from those
patients between 11 and 25 years in age.
7 Further-
more, in those cases where swabs have been
taken for persistent sore throat it would appear
that Fusobacterium necrophorum is most likely to be
the cause regardless of age.
6,8 As such, it can be
argued with some conviction that Fusobacterium
necrophorum should be included routinely in the
laboratory work-up of pharyngitis, particularly
in cases that might be considered high-risk for
the organism – for example, young adults and
individuals with persistent sore throat. Consider-
ation should also be given to the clinical history
and background when deciding upon antibiotic
therapy for bacterial pharyngitis, bearing in mind
the potential resistance of Fusobacterium necro-
phorum to both penicillins and macrolides.
Lemierre’s syndrome is an uncommon con-
dition and yet one that should not be missed
given the classical nature of its clinical history
and presentation, alongside a mortality rate of
5% in a typically young and ﬁt population. Unfor-
tunately, despite a rising incidence, many clini-
cians are unlikely to have heard of a case or even
the common causative organism, Fusobacterium
necrophorum. This knowledge is particularly rel-
evant in the primary care setting as Fusobacterium
necrophorum is increasingly recognized in the
pathogenesis of sore throat – notably persistent
or recurrent cases – and will often be resistant to
commonly prescribed antibiotics. By maintaining
an appropriate degree of clinical suspicion there
isthe potential to diagnose and treat these patients
early and effectively to the beneﬁt of all.
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